Abstract: N-unsubstituted ergolines specifically bind to human 5-HT.sub.2 receptors, and are thus useful in treating diseases such as depression, hypertension and migraine.
Abstract: A method of reducing the rate of mammalian hair growth includes topically applying a composition containing a sulfhydryl reactive compound to the skin.
Type:
Grant
Filed:
December 22, 1992
Date of Patent:
May 2, 1995
Inventors:
Douglas Shander, Gurpreet S. Ahluwalia, Diana M-D. Grosso